Cardiovascular
Read More about this categoryShow Less
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.
Research Areas
- Acute Phase Reactants(15)
- Angina(14)
- Arrhythmia(82)
- Atherosclerosis(88)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(124)
- Coronary Artery Disease(7)
- Diabetic Nephropathy(8)
- Endothelium(33)
- Erythrocytes & Hemoglobin(49)
- Heart Failure(33)
- Hypertension(162)
- Hypotension(24)
- Lipoproteins(61)
- Myocardial Contractility(33)
- Myocardial Hypertrophy(21)
- Myocardial Infarction(61)
- Others(1)
- Serum Proteins(11)
- Smooth Muscle Cells(36)
- Storage & Transport(6)
- Stroke(48)
- Thrombosis(52)
- Vasoconstriction(59)
- Vasodilation(141)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(44)
Products Related to Cardiovascular(821)
- GC90521Ornipressin (acetate)CAS: 914453-98-8Purity: >98.00%
A synthetic peptide derivative of vasopressin
- GC90529Myelin Basic Protein Peptide (mouse, bovine) (trifluoroacetate salt)Purity: >95.00%
A peptide substrate for PKC
- GC90603Tat-CIRP (trifluoroacetate salt)Purity: >95.00%
A peptide inhibitor of the MD-2-CIRP protein-protein interaction
- GC90779Shepherdin (trifluoroacetate salt)Purity: >90.00%
An inhibitor of the survivin-Hsp90 interaction
- GC908402-Chloroadenosine-5'-O-diphosphate (sodium salt)CAS: 82927-78-4Purity: >95.00%
A derivative of ADP
- GC90893Rp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt)CAS: 2005478-89-5Purity: >95.00%
An isomer of ADP-α-S
- GC90894Sp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt)CAS: 2005478-90-8Purity: >95.00%
An isomer of ADP-α-S
- GC91042Tauro-Obeticholic Acid (sodium salt)CAS: 2278141-79-8Purity: >98.00%
An active metabolite of obeticholic acid
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC90483 | Magainin 1 (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial cationic peptide | ||||
| GC90490 | PMX-53 (trifluoroacetate salt) | 514814-99-4 | >95.00% | |
A C5a receptor antagonist | ||||
| GC90516 | VK-II-86 | 955371-84-3 | >90.00% | |
An inhibitor of SOICR | ||||
| GC90521 | Ornipressin (acetate) | 914453-98-8 | >98.00% | |
A synthetic peptide derivative of vasopressin | ||||
| GC90526 | st-Ht31 (ammonium salt) | - | >98.00% | |
A cell-permeable stearated peptide | ||||
| GC90529 | Myelin Basic Protein Peptide (mouse, bovine) (trifluoroacetate salt) | - | >95.00% | |
A peptide substrate for PKC | ||||
| GC90546 | MOG Peptide (human, bovine) (acetate) | - | >95.00% | |
An endogenous myelin sheath peptide | ||||
| GC90554 | E70K (trifluoroacetate salt) | - | >98.00% | |
A peptide inhibitor of the CXCL8-GAG interaction | ||||
| GC90603 | Tat-CIRP (trifluoroacetate salt) | - | >95.00% | |
A peptide inhibitor of the MD-2-CIRP protein-protein interaction | ||||
| GC90672 | L202 | 2170488-92-1 | >95.00% | |
An ionizable cationic lipid | ||||
| GC90684 | Lipid 2,2(8,8) 4C CH3 | 2230647-30-8 | >95.00% | |
An ionizable cationic lipid | ||||
| GC90697 | Docosahexaenoic Acid-d5 ethyl ester | 159146-01-7 | >99.00% | |
N/A | ||||
| GC90700 | Dendrogenin A | 1191043-85-2 | >95.00% | |
A selective LXR modulator and ChEH inhibitor | ||||
| GC90750 | cKK-E15 | 1432494-71-7 | >95.00% | |
An ionizable cationic lipid | ||||
| GC90772 | YK-009 | 2761458-86-8 | >95.00% | |
An ionizable cationic lipid | ||||
| GC90779 | Shepherdin (trifluoroacetate salt) | - | >90.00% | |
An inhibitor of the survivin-Hsp90 interaction | ||||
| GC90822 | LAU-0901 | 727358-25-0 | >95.00% | |
A PAF receptor antagonist | ||||
| GC90840 | 2-Chloroadenosine-5'-O-diphosphate (sodium salt) | 82927-78-4 | >95.00% | |
A derivative of ADP | ||||
| GC90893 | Rp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt) | 2005478-89-5 | >95.00% | |
An isomer of ADP-α-S | ||||
| GC90894 | Sp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt) | 2005478-90-8 | >95.00% | |
An isomer of ADP-α-S | ||||
| GC90929 | Trofinetide (acetate) | - | >95.00% | |
A derivative of Gly-Pro-Glu | ||||
| GC90993 | CL4F8-6 | 2766493-12-1 | >98.00% | |
An ionizable cationic lipid | ||||
| GC91028 | L-K6L9 (trifluoroacetate salt) | - | >98.00% | |
A cytolytic peptide | ||||
| GC91042 | Tauro-Obeticholic Acid (sodium salt) | 2278141-79-8 | >98.00% | |
An active metabolite of obeticholic acid | ||||
